🔎 Trials Near Me

Akèy › Kansè Metastatik › Tennessee › Knoxville

Etid klinik pou Kansè Metastatik nan Knoxville, TN

7 etid pou Kansè Metastatik ap chèche patisipan nan sit nan ak bò kote Knoxville (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

Ap rekriteFaz 2/3
  • University of Tennessee Medical Center, Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06943755

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Ap rekriteFaz 3
  • Tennessee Cancer Specialists Dowell Springs location, Knoxville
  • University of Tennessee Medical Center, Knoxville
  • Tennessee Cancer Specialists - Parkwest Location, Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07222566

CREO - Microwave Ablation Feasibility Study

Ap rekrite
  • University of Tennessee Medical, Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT07817147

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Ap rekriteFaz 3
  • University of Tennessee Medical Center, Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT06119581

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Ap rekriteFaz 2
  • University of Tennessee Medical Center, Knoxville
Laj 18 ak plis · Tout sèks · Mizajou Aug 21, 2026 · NCT06769698

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

Ap rekriteFaz 3
  • Research Site, Knoxville
Laj 18 ak plis · Fanm · Mizajou Jul 29, 2026 · NCT07044336

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Ap rekriteFaz 2/3
  • University of Tennessee Medical Center, Knoxville
Tout laj · Tout sèks · Mizajou Apr 2, 2026 · NCT06581406

Etid Kansè Metastatik nan lòt vil

Lòt etid nan Knoxville

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.